Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: MAV, SCZ, CFG, DEI

Media Advisory - Meeting of Federal, Provincial and Territorial Ministers Responsible for Seniors


GATINEAU, QC, April 25, 2023 /CNW/ - The Federal Minister of Seniors, Kamal Khera, along with Raymond Cho, Minister for Seniors and Accessibility Ontario, will deliver remarks as co-chairs of the Meeting of Federal, Provincial and Territorial Ministers Responsible for Seniors in Mississauga, Ontario.

A media availability will follow.

Please note that all details are subject to change. All times are local.

DATE:       

Wednesday, April 26, 2023



TIME:        

3:15 p.m. EDT



PLACE:    

Hilton Toronto Airport Hotel &
Suites,


5875 Airport Road,


Mississauga, Ontario

 

Journalists who want to participate must register by contacting [email protected] with their name and media outlet before 3:00 p.m. EDT on Wednesday, April 26, 2023. Please indicate if attendance will be in-person or virtual. Zoom link will be provided upon registration.

In-person attendance instructions:

Virtual attendance instructions:

Accessibility:
The entire building is accessible.

Follow us on Twitter

SOURCE Employment and Social Development Canada


These press releases may also interest you

at 11:00
GSK plc (LSE/NYSE: GSK) today announced positive results from an interim analysis of the DREAMM-8 phase III head-to-head trial evaluating belantamab mafodotin, in combination with pomalidomide plus dexamethasone (PomDex), versus a standard of care,...

at 10:45
ConcertAI, the leading oncology real-world evidence data and AI SaaS technology company, today announced a collaboration with NVIDIA to advance a broad set of translational and clinical development solutions within the ConcertAI CARA AI platform....

at 10:25
ASRock Rack Inc., a leading innovative server company, has launched several scale-up servers leveraging the NVIDIA Blackwell architecture at the ASRock Rack booth L0818 in Hall 1 of COMPUTEX 2024. The highlights of the launch are the ORV3 NVIDIA...

at 10:05
Puma Biotechnology, Inc. , a biopharmaceutical company, announced the presentation of biomarker findings from a Phase II randomized clinical trial of alisertib alone vs. alisertib + fulvestrant for the treatment of patients with endocrine and CDK4/6...

at 10:00
Leading international medical research company, MEDSIR, today announced the results of the recent PRIMED clinical trial during the 2024 ASCO Annual...

at 10:00
Flamingo Therapeutics ("Flamingo") today announced the presentation of a Trial-in-Progress poster at the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO 2024) taking place in Chicago,...



News published on and distributed by: